US EditionAlzheimer’s diagnosed with a simple blood test
- Scientists at USC's Keck School of Medicine have created an affordable blood test called 5ADCSI that utilizes xMAP technology to detect early indicators of Alzheimer's disease.
- The test arose from the need to measure five key Alzheimer's biomarkers simultaneously with greater accessibility than costly or invasive methods like CSF collection.
- In a study involving 63 samples from individuals categorized as Alzheimer's patients, those with mild cognitive impairment, and healthy controls, the 5ADCSI blood test identified elevated biomarker concentrations, particularly p217Tau, most prominently in the Alzheimer's group.
- The test uses antibody-coated color-coded beads to capture biomarkers, with imaging sensors measuring levels, and plans exist to validate clinical reliability on hundreds of patients.
- This affordable and easier-to-use blood test could improve early diagnosis accessibility, enabling earlier preventive treatment and better management of Alzheimer's disease.
15 Articles
15 Articles
Miracle or mirage ? A detection test of the proteins linked to the disease in the blood of the sick. Authorised in the United States, this technique requires strict supervision to avoid the drive.
True, because a prototype test has recently been developed, but further studies are needed. (ANSA)
New Washington University Medicine Blood Test Can Diagnose and Track Progression of Alzheimer’s Disease with 92% Accuracy
Findings could lead to clinical laboratory test that can both track the disease’s progress and differentiate it from other forms of dementia Another research study is underway with hopes of developing a new clinical laboratory blood test to aid in the diagnoses of Alzheimer’s disease and help physicians determine the best course of treatment. Researchers […] The post New Washington University Medicine Blood Test Can Diagnose and Track Progressio…
Recently, we have known that a blood test allows to diagnose most cases of alzheimer early, when those affected have incipient symptoms of cognitive impairment. These are the results of an international study collided by the Hospital del Mar and the Center for Brain Research BarcelonaBeta (BBRC, for its initials in English).Continue reading...
El Cronista
TotalNews Agency USA EspañolA new scientific study marked a milestone in the fight against Alzheimer's: a blood test managed to identify with 90% accuracy if patients with memory problems suffer from this neurodegenerative disease. Published in JAMA magazine and presented at the International Conference of the Alzheimer's Association, this advance could transform the way in which this disease is diagnosed worldwide, facilitating access to a faster, less invasive and more a…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
